PDF) Italian Society of Hematology Practice Guidelines for the management of iron overload in thalassemia major and related disorders
2 - Haematologica - Supplements
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-
Ferrata Storti Foundation
PDF) Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia | Jacques Elion - Academia.edu
Haematologica
Untitled
Validation of Several Formulas to Differentiate Thalassemia from Iron Deficiency Anemia and Proposal of a Thalassemia–Iron Deficiency Discrimination (TID) Predictive Score | Siriraj Medical Journal
Sotatercept, a novel transforming growth factor ß ligand trap, improves anemia in ß-thalassemia: a phase II, open-label, dose-
PDF) Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies | Gian Forni - Academia.edu
Anemie
PDF) Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: Indications and management recommendations from an international expert panel
PDF) Association of anemia with health-related quality of life and survival: A large population-based cohort study
PDF) Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders | M. Marchetti - Academia.edu
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Vol. 106 No. 5 (2021): May, 2021 | Haematologica
PIEZO1 gain-of-function mutations delay reticulocyte maturation in hereditary xerocytosis. - Abstract - Europe PMC
Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia - ScienceDirect
Ferrata Storti Foundation
Non-transfusion-dependent thalassemias | Haematologica
Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from 3 decades follow-up in a hig
Haematologica, Volume 105, issue 2 by Haematologica - Issuu
Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency | Haematologica
PDF) Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
